These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8449612)

  • 1. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro.
    Pantazis P; Kozielski AJ; Mendoza JT; Early JA; Hinz HR; Giovanella BC
    Int J Cancer; 1993 Mar; 53(5):863-71. PubMed ID: 8449612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
    Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
    Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.
    Pantazis P; Mendoza JT; Early JA; Kozielski AJ; Natelson EA; Giovanella BC
    Eur J Haematol; 1993 Feb; 50(2):81-9. PubMed ID: 8440362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.
    Pantazis P; Hinz HR; Mendoza JT; Kozielski AJ; Williams LJ; Stehlin JS; Giovanella BC
    Cancer Res; 1992 Jul; 52(14):3980-7. PubMed ID: 1617674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
    Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
    Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
    J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
    Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
    Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the in vivo and in vitro conversion of 9-nitro-20(S)-camptothecin to 9-amino-20(S)-camptothecin in humans, dogs, and mice.
    Hinz HR; Harris NJ; Natelson EA; Giovanella BC
    Cancer Res; 1994 Jun; 54(12):3096-100. PubMed ID: 8205523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.
    Zamboni WC; Strychor S; Joseph E; Parise RA; Egorin MJ; Eiseman JL
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):417-26. PubMed ID: 17957368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z; Wyche JH; Sands H; Pantazis P
    Anticancer Res; 2001; 21(3B):1823-7. PubMed ID: 11497265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocols for the treatment of human tumor xenografts with camptothecins.
    Giovanella BC; Natelson E; Harris N; Vardeman D; Stehlin JS
    Ann N Y Acad Sci; 1996 Dec; 803():181-7. PubMed ID: 8993511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
    Pantazis P; Mendoza JT; DeJesus A; Rubin E; Kufe D; Giovanella BC
    Eur J Haematol; 1994 Sep; 53(3):135-44. PubMed ID: 7925856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.
    Pantazis P; Vardeman D; Mendoza J; Early J; Kozielski A; DeJesus A; Giovanella B
    Leuk Res; 1995 Jan; 19(1):43-55. PubMed ID: 7837817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of camptothecin congeners in the treatment of human breast carcinoma xenografts.
    Pantazis P; Kozielski AJ; Vardeman DM; Petry ER; Giovanella BC
    Oncol Res; 1993; 5(8):273-81. PubMed ID: 8012059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel camptothecin derivative BNP1350 in experimental human ovarian cancer: determination of efficacy and possible mechanisms of resistance.
    Van Hattum AH; Schlüper HM; Hausheer FH; Pinedo HM; Boven E
    Int J Cancer; 2002 Jul; 100(1):22-9. PubMed ID: 12115582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.
    Pantazis P; Mendoza J; DeJesus A; Early J; Shaw M; Giovanella BC
    Anticancer Drugs; 1994 Aug; 5(4):473-9. PubMed ID: 7949254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer.
    van Hattum AH; Pinedo HM; Schlüper HM; Erkelens CA; Tohgo A; Boven E
    Biochem Pharmacol; 2002 Oct; 64(8):1267-77. PubMed ID: 12234607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin.
    Dallavalle S; Ferrari A; Merlini L; Penco S; Carenini N; De Cesare M; Perego P; Pratesi G; Zunino F
    Bioorg Med Chem Lett; 2001 Feb; 11(3):291-4. PubMed ID: 11212094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.